Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Cabaletta Bio Inc.
Sponsor

Cabaletta Bio Inc.

United States 2929 Arch Street Suite 600, 19104-2857, United States

About the sponsor

Cabaletta Bio Inc. focuses on systemic lupus erythematosus, including severe autoimmune manifestations associated with lupus nephritis and broader systemic inflammation.

  • Systemic lupus erythematosus
  • Lupus nephritis
  • Autoantibody-mediated disease

The sponsor’s research interest in this area centers on B cell-driven immune dysregulation and organ-involving lupus activity.

About Specializations

Cabaletta Bio Inc. runs clinical trials in conditions such as Systemic lupus erythematosus, Autoimmune myositis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Systemic lupus erythematosus

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Caba-201
  • Sponsor:Cabaletta Bio Inc.

Autoimmune myositis

Not yet recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Caba-201
  • Sponsor:Cabaletta Bio Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.